Literature DB >> 7237432

Differential effects of cytotoxic agents on hematopoietic progenitors.

L E Botnick, E C Hannon, R Vigneulle, S Hellman.   

Abstract

In order to predict the effect of chemotherapeutic agents on the hematopoietic progenitor compartment, it is necessary to have a hypothesis concerning the dynamics of the cells within the compartment. By viewing this compartment as a continuum of cells with varying self-renewal capacity, one can assess the significance of the stem cell damage incurred following a single drug dose. Vinblastine, 5-fluorouracil, cyclophosphamide, busulfan, and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) were investigated. The acute toxicity of the drug-exposed marrow was studied by the colony-forming units-spleen (CFU-S) and agar diffusion chamber assay. Busulfan and BCNU were found to kill CFU-S preferentially. By following CFU-S recovery for 14 days post drug, different recovery patterns are noted. Busulfan and BCNU produce prolonged depression in CFU-S, whereas cyclophosphamide and 5-fluorouracil show relatively rapid recovery. If one determines the Rs (a measure of proliferative capacity) after drug, busulfan and, to a lesser extent, BCNU produce a prolonged depression without return to normal even 650 days post drug. No such depression is noted with the other drugs. The data from the recovery curves and Rs support the notion of stem cells being heterogeneous with regard to self-renewal capacity. The agar diffusion chamber and CFU-S acute survival curves would not have predicted which drugs cause significant proliferative damage. Only with the use of CFU-S recovery and ratio of CFU-S can prolonged marrow damage be ascertained.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7237432

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Deregulation of vital mitotic kinase-phosphatase signaling in hematopoietic stem/progenitor compartment leads to cellular catastrophe in experimental aplastic anemia.

Authors:  Ritam Chatterjee; Sukalpa Chattopadhyay; Sujata Law
Journal:  Mol Cell Biochem       Date:  2016-09-08       Impact factor: 3.396

2.  Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice.

Authors:  M Matsumoto; S Matsubara; T Matsuno; M Tamura; K Hattori; H Nomura; M Ono; T Yokota
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

3.  Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.

Authors:  Gustavo Mostoslavsky; Attila J Fabian; Sean Rooney; Frederick W Alt; Richard C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-24       Impact factor: 11.205

4.  A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide.

Authors:  G Molineux; C Xu; J Hendry; N G Testa
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells.

Authors:  Anne-France Petit-Bertron; François Machavoine; Marie Paule Defresne; Michel Gillard; Pierre Chatelain; Prakash Mistry; Elke Schneider; Michel Dy
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

6.  Cancer therapy-induced residual bone marrow injury-Mechanisms of induction and implication for therapy.

Authors:  Yong Wang; Virginia Probin; Daohong Zhou
Journal:  Curr Cancer Ther Rev       Date:  2006-08-01

7.  Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent.

Authors:  R Maze; J P Carney; M R Kelley; B J Glassner; D A Williams; L Samson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

8.  Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients.

Authors:  Brian C Beard; Reeteka Sud; Kirsten A Keyser; Christina Ironside; Tobias Neff; Sabine Gerull; Grant D Trobridge; Hans-Peter Kiem
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

Review 9.  Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer.

Authors:  L Bracci; G Schiavoni; A Sistigu; F Belardelli
Journal:  Cell Death Differ       Date:  2013-06-21       Impact factor: 15.828

10.  Effects of cisplatin on different haemopoietic progenitor cells in mice.

Authors:  M R Nowrousian; C G Schmidt
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.